The FTSE 100 gained 0.5%, while the CAC 40 rose 0.9% and the DAX added 0.6%
European stocks gained ground in early trade on Monday, boosted by positive vaccine news from AstraZeneca and the University of Oxford.
AstraZeneca on Monday said a vaccine it had developed with Oxford showed a 70% efficacy rate in large-scale trials. When two doses are applied, the efficacy rate rose to 90%.
It marks the third announcement in three weeks about a working COVID-19 vaccine. Pfizer and BioNTech were the first to announce they had a working vaccine candidate, while Moderna followed with a similar statement a week later.
AstraZeneca’s results show its vaccine appears to be less effective than Pfizer’s and Moderna’s jabs. Shares in AstraZeneca fell 1.5% in London.
Still, rising vaccine hopes helped to cheer European investors.
In the latest stock market news, the FTSE 100 rose half a percent at the open, while the CAC 40 was up 0.9% in France and the DAX rose 0.6% in Germany.
Investors are set to get more insight into the impact of second lockdowns on Europe’s economies as flash PMIs roll-in this morning. Data for France showed the country’s economy contracted sharply in November.
In the UK, Prime Minister Boris Johnson is set to announce the next steps on COVID-19 restrictions later today. The current national lockdown is due to end on 2 December. Press reports over the weekend suggest Johnson will announce a tougher new tier systems but say households will be allowed to mix over the Christmas period.
Stocks looked set for a higher open in New York later today. S&P 500 and Dow Jones futures were half a percent higher and Nasdaq futures were up 0.3%.
Asian stocks rose overnight, with strong gains for mainland Chinese markets. The Shanghai Composite rose 1% and the Shenzen Component rallied 0.7%. Elsewhere, the Hong Kong Hang Seng was up 0.1%, South Korea’s KOSPI surged 1.9%, and the ASX 200 added 0.3% in Australia. Markets were shut in Japan for a national holiday.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.